ENZO BIOCHEM INC ENZ (NYSE)

$ 12.25
17:39
Change: unch (unch%)
Volume: 188,826

Avg. Volume: 205046
P/E Ratio: 0
EPS (Annual): -0.29
Profit Margin:
Dividend & Yield(Annual): 0%
Shares Outstanding: 36,810
Institutional Shareholders: 47.97%
Last: 12.25
Change: unch (unch%)
Prev. Close: 12.25
Open: 12.90
Day's Range: 12.25 - 12.99
52wk Range: 7.00 - 14.90
Market Value: 473,990
Beta: .7
12-month EPS Change: 0.00%
Total Return Last 12 Months: -31.06%
Total Return Last 3 Years: -23.75%
Total Return Last 5 Years: -36.53%
5-Year Revenue Growth Rate: 0.00%
5-Year Dividend Growth Rate: 0.00%
5-Year EPS Growth Rate: 0.00%


Headlines on ENZ
Alert me Subscribe

Sector Wrap: Life Sciences

(NEW YORK)Shares of Illumina Inc. and Edwards Lifesciences hit new 52-week highs Wednesday, as a Cowen & Co. analyst said a potential increase in the National Institute of Health's fisca...READ MORE
Jun 25, 2008 3:55PM
Keywords: ILMN, EW, CBM, AFFX, DNEX, TMO, VARI, CRL, ENZ, PKI, ABI, KNDL, MIL, IVGN, PDGI, WAT, TECH, PPDI, CVD, PRXL

Market Spotlight: Life Sciences

(NEW YORK)Invitrogen Corp.'s recent $6.4 billion deal to buy Applied Biosystems Group has ramped up speculation about further consolidation in the life sciences sector, as companies vie ...READ MORE
Jun 19, 2008 1:47PM
Keywords: IVGN, ABI, HOLX, PKI, TMO, GE, A, AFFX, GPRO, ENZ, CALP, WAT, DGX, LH

Sector Snap: Invitrogen deal lifts life sciences

(NEW YORK)Invitrogen Corp.'s planned $6.4 billion buyout of Applera's Applied Biosystems Group shone a spotlight on the wider life sciences product industry Thursday, boosting invest...READ MORE
Jun 12, 2008 3:21PM
Keywords: IVGN, ABI, ENZ, PKI, TMO, CALP, WAT, DGX, AFFX, LH, PDGI, MIL, KNDL, CBM, CVD

Enzo Biochem shares rise as buyout narrows 3Q loss

(NEW YORK)Shares of Enzo Biochem Inc. jumped Tuesday after the biotech company said its third-quarter loss narrowed on sales contributions from acquisitions. The stock rose 35 cents, or 3.6 ...READ MORE
Jun 10, 2008 5:02PM
Keywords: ENZ

Enzo Biochem narrows on sales of acquired products

(NEW YORK)Biotechnology company Enzo Biochem Inc. said Monday its fiscal third-quarter loss narrowed on a rise in sales at its Enzo Life Sciences unit with the addition of acquired Axxora Li...READ MORE
Jun 09, 2008 4:46PM
Keywords: ENZ

Enzo Biochem Falls Despite Smaller Loss

(NEW YORK)Enzo Biochem says fiscal second-quarter losses were slightly smaller year-over-year, due in part to higher sales. The biotechnology company lost $4.1 million, or 11 cents per share...READ MORE
Mar 12, 2008 12:16PM
Keywords: ENZ
RSS Page | Sign up for Google Alerts


Data Provided By Barchart.com
advertisement

Top Competitors

AMGEN +30.20 60.88
AMYLIN PHARMA I -55.90 21.48
GILEAD SCIENCES +22.60 49.98
BIOGEN IDEC INC -21.40 48.16
GENENTECH INC +33.70 96.50